University of Florida neuroscientists have made a mechanistic discovery that paves the way to test immune-modulating medicines as a potential tool to break the cycle of methamphetamine addiction.
In a preclinical study, a McKnight Brain Institute team led by Habibeh Khoshbouei, Ph.D., Pharm.D., examined the role of neuroinflammation in meth addiction to provide a deeper understanding of the mechanisms at work.
Read more about Unexpected Finding Could Offer New Treatment Targets for Meth Addiction.
